Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0596887
Disease: mathematical ability
mathematical ability
0.100 GeneticVariation phenotype GWASCAT Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. 30038396 2018
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7
0.700 CausalMutation disease CLINVAR Adult Onset Leigh Syndrome in the Intensive Care Setting: A Novel Presentation of a C12orf65 Related Mitochondrial Disease. 27858754 2015
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7
0.700 GeneticVariation disease CLINVAR Adult Onset Leigh Syndrome in the Intensive Care Setting: A Novel Presentation of a C12orf65 Related Mitochondrial Disease. 27858754 2015
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7
0.700 Biomarker disease GENOMICS_ENGLAND Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. 27604308 2016
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE
0.610 Biomarker disease GENOMICS_ENGLAND Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. 27604308 2016
CUI: C0029124
Disease: Optic Atrophy
Optic Atrophy
0.150 Biomarker disease BEFREE Some reported cases have been found to carry mutations in the OPA1, OPA3 or C12ORF65 genes which are known causes of pure optic atrophy or optic atrophy complicated by movement disorder. 26187298 2015
CUI: C0026650
Disease: Movement Disorders
Movement Disorders
0.010 Biomarker group BEFREE Some reported cases have been found to carry mutations in the OPA1, OPA3 or C12ORF65 genes which are known causes of pure optic atrophy or optic atrophy complicated by movement disorder. 26187298 2015
CUI: C0023264
Disease: Leigh Disease
Leigh Disease
0.020 GeneticVariation disease BEFREE Homozygous p.V116* mutation in C12orf65 results in Leigh syndrome. 25995486 2016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7
0.700 Biomarker disease GENOMICS_ENGLAND Delineation of C12orf65-related phenotypes: a genotype-phenotype relationship. 24424123 2014
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE
0.610 Biomarker disease GENOMICS_ENGLAND Delineation of C12orf65-related phenotypes: a genotype-phenotype relationship. 24424123 2014
CUI: C0029124
Disease: Optic Atrophy
Optic Atrophy
0.150 Biomarker disease BEFREE Our study broadens the phenotypic spectrum of C12orf65 defects and highlights the triad of optic atrophy, axonal neuropathy and spastic paraparesis as its key clinical features. 24424123 2014
CUI: C0037771
Disease: Paraparesis, Spastic
Paraparesis, Spastic
0.110 Biomarker phenotype BEFREE C12orf65 participates in the process of mitochondrial translation and has been shown to be associated with a spectrum of phenotypes, including early onset optic atrophy, progressive encephalomyopathy, peripheral neuropathy, and spastic paraparesis.We used whole-genome homozygosity mapping as well as exome sequencing and targeted gene sequencing to identify novel C12orf65 disease-causing mutations in seven affected individuals originating from two consanguineous families. 24424123 2014
CUI: C0031117
Disease: Peripheral Neuropathy
Peripheral Neuropathy
0.010 Biomarker group BEFREE C12orf65 participates in the process of mitochondrial translation and has been shown to be associated with a spectrum of phenotypes, including early onset optic atrophy, progressive encephalomyopathy, peripheral neuropathy, and spastic paraparesis.We used whole-genome homozygosity mapping as well as exome sequencing and targeted gene sequencing to identify novel C12orf65 disease-causing mutations in seven affected individuals originating from two consanguineous families. 24424123 2014
CUI: C4721453
Disease: Peripheral Nervous System Diseases
Peripheral Nervous System Diseases
0.010 Biomarker group BEFREE C12orf65 participates in the process of mitochondrial translation and has been shown to be associated with a spectrum of phenotypes, including early onset optic atrophy, progressive encephalomyopathy, peripheral neuropathy, and spastic paraparesis.We used whole-genome homozygosity mapping as well as exome sequencing and targeted gene sequencing to identify novel C12orf65 disease-causing mutations in seven affected individuals originating from two consanguineous families. 24424123 2014
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7
0.700 GeneticVariation disease CLINVAR Optic atrophy and a Leigh-like syndrome due to mutations in the c12orf65 gene: report of a novel mutation and review of the literature. 24284555 2014
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7
0.700 CausalMutation disease CLINVAR Optic atrophy and a Leigh-like syndrome due to mutations in the c12orf65 gene: report of a novel mutation and review of the literature. 24284555 2014
CUI: C0029124
Disease: Optic Atrophy
Optic Atrophy
0.150 GeneticVariation disease BEFREE Optic atrophy and a Leigh-like syndrome due to mutations in the c12orf65 gene: report of a novel mutation and review of the literature. 24284555 2014
CUI: C0023264
Disease: Leigh Disease
Leigh Disease
0.020 GeneticVariation disease BEFREE We describe 2 siblings with compound heterozygous mutations in the recently identified C12orf65 gene who presented with optic atrophy and mild developmental delays and subsequently developed bilateral, symmetric lesions in the brainstem reminiscent of Leigh syndrome. 24284555 2014
CUI: C0029124
Disease: Optic Atrophy
Optic Atrophy
0.150 GeneticVariation disease BEFREE We described a large consanguineous family with neuropathy and optic atrophy carrying a loss of function mutation in the C12orf65 gene. 24198383 2014
CUI: C0270921
Disease: Axonal neuropathy
Axonal neuropathy
0.010 GeneticVariation disease BEFREE This work describes a mutation in the C12orf65 gene that causes recessive form of CMT6 and confirms the role of mitochondrial dysfunction in this complex axonal neuropathy. 24198383 2014
CUI: C0029089
Disease: Ophthalmoplegia
Ophthalmoplegia
0.110 GeneticVariation phenotype BEFREE Considering our findings, we now conclude that truncating mutations in C12ORF65 lead to a variable phenotype with intellectual disability, spastic paraplegia, and ophthalmoplegia as common symptoms. 24080142 2013
CUI: C0038379
Disease: Strabismus
Strabismus
0.110 GeneticVariation disease BEFREE Homozygosity mapping and exome sequencing in two affected siblings of a consanguineous family with mild intellectual disability, spastic paraplegia, and strabismus revealed a homozygous premature stop mutation at codon 139 of C12ORF65. 24080142 2013
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.010 GeneticVariation group BEFREE Considering our findings, we now conclude that truncating mutations in C12ORF65 lead to a variable phenotype with intellectual disability, spastic paraplegia, and ophthalmoplegia as common symptoms. 24080142 2013
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.100 GeneticVariation disease GWASDB Genome-wide association analysis identifies 13 new risk loci for schizophrenia. 23974872 2013
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.100 GeneticVariation disease GWASCAT Genome-wide association analysis identifies 13 new risk loci for schizophrenia. 23974872 2013